Company

Ocular Therapeutix, Inc.

Ocular Therapeutix develops ophthalmic therapies and products for eye surgery.

About

Ocular Therapeutix develops ophthalmic therapies and products for eye surgery. Its portfolio includes DEXTENZA® and ReSure® Sealant, and it is developing therapies using ELUTYX™ technology for retinal diseases, glaucoma, and other eye conditions. Founded in 2006, the company is based in Bedford, US, and is at the Series D stage.

7Funding rounds

13Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in